Literature DB >> 16214581

The PROactive study: some answers, many questions.

Hannele Yki-Järvinen1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16214581     DOI: 10.1016/S0140-6736(05)67504-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  24 in total

1.  Pathophysiological role of enhanced bone marrow adipogenesis in diabetic complications.

Authors:  Meghan A Piccinin; Zia A Khan
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

Review 2.  Pioglitazone: a review of its use in type 2 diabetes mellitus.

Authors:  John Waugh; Gillian M Keating; Greg L Plosker; Stephanie Easthope; Dean M Robinson
Journal:  Drugs       Date:  2006       Impact factor: 9.546

3.  The market in diabetes.

Authors:  Alexandra Hauber; Edwin A M Gale
Journal:  Diabetologia       Date:  2006-02       Impact factor: 10.122

4.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

Review 5.  Molecular insights and therapeutic targets for diabetic endothelial dysfunction.

Authors:  Jian Xu; Ming-Hui Zou
Journal:  Circulation       Date:  2009-09-29       Impact factor: 29.690

6.  The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes.

Authors:  George R Beck; Natasha B Khazai; Gary F Bouloux; Corinne E Camalier; Yiming Lin; Laura M Garneys; Joselita Siqueira; Limin Peng; Francisco Pasquel; Denise Umpierrez; Dawn Smiley; Guillermo E Umpierrez
Journal:  Transl Res       Date:  2012-09-27       Impact factor: 7.012

7.  Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial.

Authors:  Z Punthakee; J Bosch; G Dagenais; R Diaz; R Holman; J L Probstfield; A Ramachandran; M C Riddle; L E Rydén; B Zinman; R Afzal; S Yusuf; H C Gerstein
Journal:  Diabetologia       Date:  2011-10-29       Impact factor: 10.122

Review 8.  Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review.

Authors:  Dean T Eurich; Finlay A McAlister; David F Blackburn; Sumit R Majumdar; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2007-08-30

9.  Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma Agonists.

Authors:  Martin B Oleksiewicz; Jennifer Southgate; Lars Iversen; Frederikke L Egerod
Journal:  PPAR Res       Date:  2009-01-28       Impact factor: 4.964

Review 10.  Glucose control and cardiovascular disease: is it important? No.

Authors:  Ignacio Conget; Marga Giménez
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.